Compare Cigna Corp (CI) vs PepsiCo, Inc. (PEP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs PepsiCo, Inc. — how do they compare? Cigna Corp trades at $302.09 (market cap $80.55B), while PepsiCo, Inc. trades at $135.71 (market cap $189.02B). The key difference: PepsiCo, Inc. is far larger — about 2.3× Cigna Corp's market cap, and PepsiCo, Inc. pays the higher dividend (4.27%). Which is the better fit depends on your goals.
| CI | PEP | |
|---|---|---|
Market Cap | $80.55B | $189.02B |
Sector | Health | Consumer Staples |
52-Week High | $311.00 | $170.44 |
52-Week Low | $244.41 | $133.81 |
Enterprise Value | $103.65B | $231.52B |
Dividend Yield | 2.05% | 4.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $304.50, up 3.76% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q1 2026 EPS of $7.79 exceeding the $7.60 estimate. Valuation metrics appear attractive with a P/E of 12.91 and P/S of 0.29. Recent news highlights strategic AI investments in pharmacy services and positive sector sentiment.
The investment case centers on undervaluation, earnings momentum, and dividend yield, though risks include regulatory challenges and moderating cash flow. With a consensus price target of $339.82 implying 11.6% upside, Wall Street maintains a bullish stance, but investors should weigh execution risks against growth initiatives.
PepsiCo (PEP) trades at $138.49, up 0.81% with bearish technical signals but strong fundamentals. The stock shows consistent earnings beats with Q2 2026 EPS of $2.20 exceeding expectations. Revenue growth remains steady at $93.93B in 2025, while profit margins improved to 10.78% net income margin. Recent news highlights price adjustments in snack portfolio and institutional accumulation despite technical headwinds.
PepsiCo presents a mixed outlook with strong fundamentals offset by technical weakness. The company's 33% upside to consensus price target of $159.27 offers potential, but investors face risks from consumer pricing sensitivity and competitive pressures. The stock's high ROE (51.59%) and dividend yield near 4% provide defensive characteristics amid market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About PepsiCo, Inc.
PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →
